These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients. Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000 [TBL] [Abstract][Full Text] [Related]
4. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population. Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270 [TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population. Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057 [TBL] [Abstract][Full Text] [Related]
6. Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers. Sharma V; Young L; Allison AB; Owen K; ; Elife; 2016 Feb; 5():. PubMed ID: 26894955 [TBL] [Abstract][Full Text] [Related]
7. Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Khan I; Kerwin J; Owen K; Griner E; ; Elife; 2015 Sep; 4():. PubMed ID: 26335297 [TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea. Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749 [TBL] [Abstract][Full Text] [Related]
9. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352 [TBL] [Abstract][Full Text] [Related]
10. Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Bhargava A; Pelech S; Woodard B; Kerwin J; Maherali N; ; Elife; 2016 Feb; 5():. PubMed ID: 26882073 [TBL] [Abstract][Full Text] [Related]
11. Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Evans J; Essex A; Xin H; Amitai N; Brinton L; Griner E; ; Elife; 2015 Aug; 4():. PubMed ID: 26287525 [TBL] [Abstract][Full Text] [Related]
12. Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Lesnik J; Antes T; Kim J; Griner E; Pedro L; ; Elife; 2016 Jan; 5():e07383. PubMed ID: 26826285 [TBL] [Abstract][Full Text] [Related]
13. Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Bhargava A; Anant M; Mack H; ; Elife; 2016 Feb; 5():. PubMed ID: 26885666 [TBL] [Abstract][Full Text] [Related]
14. Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840 [TBL] [Abstract][Full Text] [Related]
15. Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia. Fung JJ; Kosaka A; Shan X; Danet-Desnoyers G; Gormally M; Owen K; ; Elife; 2015 Sep; 4():. PubMed ID: 26327698 [TBL] [Abstract][Full Text] [Related]
16. Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells. Vanden Heuvel JP; Bullenkamp J; Elife; 2016 Jun; 5():. PubMed ID: 27336789 [TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients. Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996 [TBL] [Abstract][Full Text] [Related]
18. High occurrence of Fusobacterium nucleatum and Clostridium difficile in the intestinal microbiota of colorectal carcinoma patients. Fukugaiti MH; Ignacio A; Fernandes MR; Ribeiro Júnior U; Nakano V; Avila-Campos MJ Braz J Microbiol; 2015; 46(4):1135-40. PubMed ID: 26691472 [TBL] [Abstract][Full Text] [Related]
19. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment. Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137 [TBL] [Abstract][Full Text] [Related]
20. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum. Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]